...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZCC as opposed to Zenith Epigenetics

Some time ago Zenith split into two. For some reason I had been thinking it was going to be the same spinco terms as RVX to Zenith but just realized the error of my ways. The AGM on Dec 15th is for Zenith Capital Corp which we hold common shares in (i am assuming that posters on this forum are Zenith holders). If i am remembering correctly Zenith Epigenetics holds the intellectual property and ZCC holds basically the royalty rights. I also believe that at this point in time all shares in Zenith Epigenetics are held by Zenith Epigenetics. I also think I recall that ZE is a wholly owned subsidiary of ZCC. So what happens if some part or a whole of ZE is sold?

Share
New Message
Please login to post a reply